MDR-001
A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight Participants
MindRank AI Ltd · Phase 1/2 · Completed · Enrollment 128
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| MDR-001(SAD) | n/r | n/r | n/r | n/r | n/r |
| Placebo (SAD) | n/r | n/r | n/r | n/r | n/r |
| MDR-001 (MAD) | n/r | n/r | n/r | n/r | n/r |
| Placebo (MAD) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.